Skip to main content
PMC Canada Author Manuscripts logoLink to PMC Canada Author Manuscripts
. Author manuscript; available in PMC: 2011 Apr 28.
Published in final edited form as: Bioorg Med Chem Lett. 2008 Sep 6;18(20):5518–5522. doi: 10.1016/j.bmcl.2008.09.004

Synthesis and Use of Sulfonamide-, Sulfoxide-, or Sulfone-containing Aminoglycoside-CoA Bisubstrates as Mechanistic Probes for Aminoglycoside N-6′-Acetyltransferase§

Feng Gao 1,a,, Xuxu Yan 1,, Omar Zahr 1, Aaron Larsen 1, Kenward Vong 1, Karine Auclair 1,*
PMCID: PMC3084191  CAMSID: CAMS1738  PMID: 18805003

Abstract

Aminoglycoside-coenzyme A conjugates are challenging synthetic targets because of the wealth of functional groups and high polarity of the starting materials. We previously reported a one-pot synthesis of amide-linked aminoglycoside-CoA bisubstrates. These molecules are nanomolar inhibitors of aminoglycoside N-6′-acetyltransferase Ii (AAC(6′)-Ii), an important enzyme involved in bacterial resistance to aminoglycoside antibiotics. We report here the synthesis and biological activity of five new aminoglycoside-CoA bisubstrates containing sulfonamide, sulfoxide, or sulfone groups. Interestingly, the sulfonamide-linked bisubstrate, which was expected to best mimic the tetrahedral intermediate, does not show improved inhibition when compared with amide-linked bisubstrates. On the other hand, most of the sulfone- and sulfoxide-containing bisubstrates prepared are nanomolar inhibitors of AAC(6′)-Ii.

Keywords: antibiotic, inhibition, neamine, resistance


Aminoglycosides are broad spectrum antimicrobials.1 Unfortunately, widespread resistance to aminoglycosides threatens the use of this important class of antibiotics, alone or in synergistic combination with β-lactams. Resistance to aminoglycosides occurs mostly via drug modifications by enzymes such as aminoglycoside N-6′-acetyltransferases (AAC(6′)s).27 Wright and coworkers have shown that catalysis by AAC(6′)-Ii proceeds via an ordered bi-bi mechanism in which acetyl coenzyme A (AcCoA) binds before the aminoglycoside.9 Attack of the aminoglycoside 6′-NH2 at the thioester of AcCoA is believed to generate a tetrahedral intermediate, which subsequently collapses to yield a 6′-N-acetylaminoglycoside and CoA (Fig. 1).810 Extensive mutagenic studies9,10 and examination of the crystal structures of AAC(6′)-Ii17,18 have not allowed the identification of residues that may stabilize the tetrahedral intermediate.

Figure 1.

Figure 1

Proposed chemical steps catalyzed by AAC(6′)-Ii (top). Previously reported amide-linked aminoglycoside-CoA bisubstrate inhibitors (1a-b) and bisubstrate inhibitors synthesized and tested here (2a-b, 3a-b and 4a-b).

We recently reported the use of amide-linked aminoglycoside-CoA bisubstrate inhibitors as mechanistic and structural probes of (AAC(6′)s. An effective regio- and chemo-selective protocol for the direct N-6′-derivatization of unprotected aminoglycosides was used to synthesize these inhibitors in one-pot (Fig. 1, 1a-b).11, 12 These molecules exhibited nanomolar inhibition towards AAC(6′)-Ii and allowed crystallization of AAC(6′)-Ii in complex with an aminoglycoside derivative for the first time.11

To improve inhibition and to investigate whether AAC(6′)-Ii stabilizes the tetrahedral intermediate, we envisaged to prepare a second generation of bisubstrates containing either a sulfonamide, sulfoxide or sulfone, expected to better mimic the tetrahedral intermediate (Fig. 1, 2a-b, 3a-b and 4a-b). We hypothesized that if stabilization of this intermediate is important, a better mimetic would lead to increased affinity for the enzyme. Oxidized sulfides were selected for their ease of preparation, the higher polarizability of the S=O bond compared to a carbonyl, and the tetrahedral geometry at the sulfur atom. Sulfonamides have previously been used to mimic the tetrahedral intermediates involved in enzymatic catalysis by proteases13 arginase,14 dihydroorotase,15 and isoleucyl tRNA synthetase (Ki = 0.04 nM).16

The crystal structures of AAC(6′)-Ii in complex with AcCoA (Fig. 2),17 CoA18 or bisubstrate inhibitors11 all reveal the presence of two hydroxyl groups, Tyr147-OH (3.71 Å away) and Thr111-OH (4.31 Å away), near the CoA sulfur atom. We reasoned that oxidization of the sulfur atom of bisubstrates 1a-b into sulfoxides 3a-b or sulfones 4a-b may also increase the affinity for the enzyme by allowing two extra H-bonds between the oxygen of S=O and these two hydrogen donors.

Figure 2.

Figure 2

A) Crystal structure of AAC(6′)-Ii in complex with AcCoA (1B87.pdb, figure produced using PyMol)17. The protein is represented with cartoon. Tyr147, Thr111, and AcCoA are represented with line and colored by C (green), O (red), N (blue), P (purple), and the sulfur atom of AcCoA is represented as a yellow sphere. B) Chemical structure of AcCoA and the distance between the sulfur and two amino acid residues.

We report here the synthesis of bisubstrates 2b, 3a-b, 4a-b and their effect on the activity of AAC(6′)-Ii.

Bromomethanesulfonyl chloride (6a) was used as the main building block for the assembly of 1a-b. Compound 6a was assembled by reacting sodium bromomethylsulfonate (5a) with PCl5 as previously reported (Scheme 1).19 Compound 5a was prepared using a reported procedure with some modifications.20 Thus, sodium sulfite and dibromomethane were refluxed in a mixture of ethanol and water in the presence of a catalytic amount of tetrabutylammonium hydrogen sulfate (2 mol%), to afford crystalline product 5a. 1,3,2′-tri-N-(tert-Butoxycarbonyl)neamine (10) was prepared using a known procedure.21 N-Benzyloxycarbonyloxy-5-norbornene-endo-2,3-dicarboximide (7) was used to regioselectively protect the 6′-NH2 of neamine and generate 8 in good yield. Treatment of 8 with di-tert-butyl dicarbonate (Boc anhydride) protected all the remaining amino groups of neamine to yield 9, which was debenzylated to afford 10. Compound 10 reacted with 6a to afford 11a, which was deprotected to give 12a, N-6′-bromomethylsulfonyl neamine (Scheme 1).

Scheme 1.

Scheme 1

First synthetic attempt to prepare bisubstrate analog 2a.

Unfortunately, bromide 12a did not react with CoA (shown as CoA-SH in synthetic schemes). We suspected that this lack of reactivity was due to the low electrophilicity of the bromomethylene carbon. To confirm this hypothesis, we carried out two model reactions (Scheme 2) to compare the reactivity of bromomethyl sulfonamide and iodomethanesulfonamide toward sulfhydryl nucleophile. Indeed, when N-benzyl bromomethanesulfonamide (Scheme 2, 13a) was treated with N-acetylcysteamine (a surrogate for CoA) in an aqueous solvent for two days at RT, no product (14) was detectable. The iodomethanesulfonamide 13b, however, reacted with N-acetylcysteamine to yield product 14 under the same conditions after 2 days at RT. Encouraged by this, we set out to prepare the corresponding iodide. A synthetic pathway similar to that described for 12a was used. Surprisingly, removal of the Boc group followed by chromatography on silica gel led to reduction of the product to 6′-N-methanesulfonylneamine (12b). Reduction of the iodomethanesulfonamide was also observed in the model reaction but only as a minor product.22

Scheme 2.

Scheme 2

Model reaction for thiol attack at halomethanesulfonamides.

Previous studies with amide-linked bisubstrates11 show that linkers with n = 2 are slightly more potent than those with n = 1. We thus embarked on the synthesis of bisubstrate 2b (Fig. 1). Retrosynthetic analysis suggests compound 15 (Scheme 3A) as a reasonable intermediate. Again, a model reaction was used to evaluate the feasibility of this synthetic approach (Scheme 3B). Not surprisingly, the β-bromosulfinamide 16a easily eliminated to give a mixture of 16a and the vinylsulfonamide 16b. With 2.5 equivalents of base, 16b was the only isolated product. Vinylsulfinamides are known to be susceptible to Michael addition by sulfhydryl groups.2326 To optimize the reaction conditions, vinylsulfinamide 16b was reacted with N-acetyl cysteamine (Scheme 3B). In the presence of triethylamine (TEA), the reaction was complete within 30 min and afforded adduct 17. Next, 2-bromoethanesulfonyl chloride (6c) was reacted with protected neamine 10 to yield the vinylsulfinamide 18 after spontaneous bromide elimination (Scheme 3C). Deprotection of 18 yielded 19 as the trifluoroacetate salt. Attempts to purify this intermediate on silica gel led to decomposition of the product. Crude 19 was therefore used directly in a reaction with CoA, which yielded bisubstrate 2b in >35% yield after reverse phase HPLC purification (only part of the sample was purified).

Scheme 3.

Scheme 3

Model reaction and synthesis of bisubstrate 2b.

Bisubstrates 3a-b and 4a-b were next prepared by direct oxidation of the known sulfides 1a-b. Selective oxidation of sulfides to sulfoxides has interested chemists for many years.2735 Magnesium monoperoxyphthalate (MMPP) was reported to selectively oxidize glycosyl sulfides to sulfoxides31, 36 or sulfones37 in good yields. Thus MMPP appeared as the most suitable oxidant for our purpose. Unfortunately, the oxidation of 1b with MMPP was very slow. Half of the starting material remained unchanged after one hour at RT in the presence of 3 equivalents of MMPP. Furthermore, only the sulfoxide product was observed under these conditions. Longer reaction times led to decomposition of the reactants and product. m-Chloroperbenzoic acid (m-CPBA),3840 sodium periodate,4144 tert-butylhydroperoxide (TBHP),34, 4547 Oxone,34, 4851 N-sulfonyloxaziridine,33 and dioxirane50 have also been used for the selective oxidation of sulfides to sulfoxides. Except for N-sulfonyloxaziridines, all of these reagents, and more, were explored for the oxidation of 1b. The results are summarized in Table 1.

Table 1.

Screening of oxidants for the selective sulfide oxidation of 1b

Oxidanta Equiv. Sulfide Resultsb Sulfoxide Sulfone
MMPP 3 >90% <10% 0
mCPBA 3 60% 40% 0
TBHP 3 90% 10% 0
H2O2 3 60% 40% 0
H2O2 Urea 3 100% 0 0
H2O2 Na2CO3 3 decomposition
H2O2 Na2BO2 3 decomposition
NaIO4 3 decomposition
NaIO4 1 50% 50% 0
(NH4)2S2O8 1 50% 50% 0
(NH4)2S2O8 2 0 100% 0
Oxonec 1 0 60% 40%
Oxone 2 0 0 100%
a

reaction time is 1 h at RT in water;

b

composition was normalized according to corresponding peak area from LC-MS;

c

potassium monopersulfate as in 2KHSO5 · KHSO4 · K2SO4.

Ammonium persulfate was the best oxidant for the selective oxidation of the sulfide 1a and 1b to the corresponding sulfoxides 3a and 3b (Scheme 4). The reactions were complete within one hour when two equivalents of oxidant were used. To our knowledge, this is the first time that (NH4)2SO8 is successfully used for the selective oxidation of a sulfide containing multiple functionalities, to a sulfoxide under aqueous conditions. Bisubstrates 3a-b were purified by reverse phase HPLC. One of two possible diastereoisomers was major (>90%) and the minor isomer was discarded. No attempt was made to determine the absolute stereochemistry at the sulfur atom because of the prohibitive cost of CoA. As for the oxidation of the sulfides 1a and 1b to sulfones 4a and 4b respectively, oxone appeared to be the most efficient oxidant (Scheme 4).

Scheme 4.

Scheme 4

Optimized conditions for the syntheses of bisubstrates 3a-b and 4a-b via the selective oxidation of the sulfides 1a-b.

The bisubstrates 2b, 3a-b and 4a-b were tested for inhibition of AAC(6′)-Ii. The results are shown in Table 2. The large error reported for the Ki of 4a can be explained by the hygroscopic nature of this compound, which decreased the accuracy of weight measurements. All compounds tested were potent competitive inhibitors with Kis ranging from low micromolar to nanomolar. Surprisingly, the bisubstrate with a sulfonamide linker (2b) showed a decreased inhibition compared to the corresponding amide-linked bisubstrate (1b). This result suggests either that the enzyme does not stabilize the tetrahedral intermediate or that 2b is a poor mimic of the tetrahedral intermediate. The synthesis of phosphonate-linked bisubstrates is currently under way to verify these hypotheses.

Table 2.

AAC(6′)-Ii inhibition constants (Ki) for bisubstrates 2b, 3a-b and 4a-b

Inhibitor 2b 3a 3b 4a 4b
Type competitive competitive competitive competitive competitive
Ki (μM) 1.6 ± 0.6 0.06 ± 0.03 2.0 ± 0.7 0.27 ± 0.2 0.09 ± 0.06

In conclusion, we report here the synthesis of 5 new bisubstrates containing a sulfonamide linker, or an amide linker adjacent to sulfoxide or sulfone groups. Four of these bisubstrates were assembled in only 2 steps. We demonstrate for the first time the utility of (NH4)2S2O8 in the selective oxidation of highly functionalized sulfides to sulfoxides under aqueous conditions. Although sulfonamides are expected to better mimic tetrahedral intermediates than amides, sulfonamide-linked bisubstrate 2b showed poorer inhibition of AAC(6′)-Ii than amide-linked inhibitor 1b. This supports the hypothesis that AAC(6′)-Ii may catalyze the reaction mainly via proximity effects.

Supplementary Material

Supporting Information

Acknowledgments

This work was supported by the National Science and Engineering Research Council of Canada (NSERC) and by the Canadian Institute of Health Research (CIHR). A.L. was supported by an NSERC scholarship. F.G. and K.V. were supported by scholarship awards from the Chemical Biology Strategic Training Initiative of CIHR. The authors are grateful to G. D. Wright at McMaster University for sharing his AAC(6′)-Ii expression plasmid.

Footnotes

§

Detailed descriptions of experimental procedures and characterization of all compounds are available as Supporting Information.

References and notes

  • 1.Gonzalez LSS, III, Jeanne P. Am Fam Physician. 1998;58:181. [Google Scholar]
  • 2.Vakulenko SB, Mobashery S. Clin Microbiol Rev. 2003;16:430. doi: 10.1128/CMR.16.3.430-450.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wright GD. Curr Opin Microbiol. 1999;2:499. doi: 10.1016/s1369-5274(99)00007-7. [DOI] [PubMed] [Google Scholar]
  • 4.Wright GD. Curr Opin Chem Biol. 2003;7:563. doi: 10.1016/j.cbpa.2003.08.004. [DOI] [PubMed] [Google Scholar]
  • 5.Azucena E, Mobashery S. Drug Resist Update. 2001;4(2):106. doi: 10.1054/drup.2001.0197. [DOI] [PubMed] [Google Scholar]
  • 6.Boehr DD, Moore IF, Wright GD. Front Antimicrob Resist. 2005:85. [Google Scholar]
  • 7.Magnet S, Blanchard JS. Chem Rev. 2005;105:477. doi: 10.1021/cr0301088. [DOI] [PubMed] [Google Scholar]
  • 8.Wright GD, Ladak P. Antimicrob Agents Ch. 1997;41:956. doi: 10.1128/aac.41.5.956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Draker KA, Wright GD. Biochemistry. 2004;43:446. doi: 10.1021/bi035667n. [DOI] [PubMed] [Google Scholar]
  • 10.Draker KA, Northrop DB, Wright GD. Biochemistry. 2003;42:6565. doi: 10.1021/bi034148h. [DOI] [PubMed] [Google Scholar]
  • 11.Gao F, Yan X, Baettig OM, Berghuis AM, Auclair K. Angew Chem Int Edit. 2005;44:6859. doi: 10.1002/anie.200501399. [DOI] [PubMed] [Google Scholar]
  • 12.Gao F, Yan X, Shakya T, Baettig OM, Ait-Mohand-Brunet S, Berghuis AM, Wright GD, Auclair K. J Med Chem. 2006;49:5273. doi: 10.1021/jm060732n. [DOI] [PubMed] [Google Scholar]
  • 13.Obreza A, Gobec S. Curr Med Chem. 2004;11:3263. doi: 10.2174/0929867043363659. [DOI] [PubMed] [Google Scholar]
  • 14.Cama E, Shin H, Christianson DW. J Am Chem Soc. 2003;125:13052. doi: 10.1021/ja036365b. [DOI] [PubMed] [Google Scholar]
  • 15.Levenson CH, Meyer RB. J Med Chem. 1984;27:228. doi: 10.1021/jm00368a022. [DOI] [PubMed] [Google Scholar]
  • 16.Brown MJB, Mensah LM, Doyle ML, Broom NJP, Osbourne N, Forrest AK, Richardson CM, O’Hanlon PJ, Pope AJ. Biochemistry. 2000;39:6003. doi: 10.1021/bi000148v. [DOI] [PubMed] [Google Scholar]
  • 17.Wybenga-Groot LE, Draker KA, Wright GD, Berghuis AM. Structure. 1999;7:497. doi: 10.1016/s0969-2126(99)80066-5. [DOI] [PubMed] [Google Scholar]
  • 18.Burk DL, Ghuman N, Wybenga-Groot LE, Berghuis AM. Protein Sci. 2003;12:426. doi: 10.1110/ps.0233503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Truce WE, Abraham DJ, Son P. J Org Chem. 1967;32:990. doi: 10.1021/jo01279a031. [DOI] [PubMed] [Google Scholar]
  • 20.Brienne MJ, Varech D, Leclercq M, Jacques J, Radembino N, Dessalles C, Mahuzier G, Gueyouche C, Bories C, et al. J Med Chem. 1987;30:2232. doi: 10.1021/jm00395a010. [DOI] [PubMed] [Google Scholar]
  • 21.Roestamadji J, Grapsas I, Mobashery S. J Am Chem Soc. 1995;117:11060. [Google Scholar]
  • 22.Note, 1H NMR (DMSO-d6, 300 MHz) d 8.00 (s, 1H), 7.30 (m, 5H), 4.14 (d, J = 5.4, 2H), 3.32 (s, 3H); 13C NMR (DMSO-d6, 75 MHz) d 136.8, 129.0, 128.3, 127.8, 47.3, 40.4.
  • 23.Truce WE, Wellisch E. J Am Chem Soc. 1952;74:2881. [Google Scholar]
  • 24.Li M, Wu RS, Tsai JSC, Salamone SJ. Bioorg Med Chem Lett. 2003;13:383. doi: 10.1016/s0960-894x(02)00950-2. [DOI] [PubMed] [Google Scholar]
  • 25.Reddick JJ, Cheng J, Roush WR. Org Let. 2003;5:1967. doi: 10.1021/ol034555l. [DOI] [PubMed] [Google Scholar]
  • 26.Zhao MM, Qu C, Lynch JE. J Org Chem. 2005;70:6944. doi: 10.1021/jo050500g. [DOI] [PubMed] [Google Scholar]
  • 27.Baeckvall J-E. Modern Oxidation Methods. 2004:193. [Google Scholar]
  • 28.Legros J, Dehli JR, Bolm C. Adv Syn Catal. 2005;347:19. [Google Scholar]
  • 29.Mata EG. Phosphorus Sulfur. 1996;117:231. [Google Scholar]
  • 30.Chen BC, Murphy CK, Kumar A, Reddy RT, Clark C, Zhou P, Lewis BM, Gala D, Mergelsberg I, Scherer D, Buckley J, DiBenedetto D, Davis FA. Org Syn. 1996;73:159. [Google Scholar]
  • 31.Chen MY, Patkar LN, Lin CC. J Org Chem. 2004;69:2884. doi: 10.1021/jo035698o. [DOI] [PubMed] [Google Scholar]
  • 32.Chen MY, Patkar LN, Chen HT, Lin CC. Carbohyd Res. 2003;338:1327. doi: 10.1016/s0008-6215(03)00164-2. [DOI] [PubMed] [Google Scholar]
  • 33.Davis FA, Lal SG, Durst HD. J Org Chem. 1988;53:5004. [Google Scholar]
  • 34.Kropp PJ, Breton GW, Fields JD, Tung JC, Loomis BR. J Am Chem Soc. 2000;122:4280. [Google Scholar]
  • 35.Kagan HB. Asymmetric oxidation of sulfides. In: Ojima I, editor. Catalytic Asymmetric Synthesis. Wiley-VCH; 2000. pp. 327–356. [Google Scholar]
  • 36.Velasco MA. Synlett. 2005;11:1807. [Google Scholar]
  • 37.Arjona O, Menchaca R, Plumet J. J Org Chem. 2001;66:2400. doi: 10.1021/jo001660p. [DOI] [PubMed] [Google Scholar]
  • 38.Arai Y, Matsui M, Koizumi T. Synthesis. 1990;4:320–323. [Google Scholar]
  • 39.Brougham P, Cooper MS, Cummerson DA, Heaney H, Thompson N. Synthesis. 1987;11:1015–1017. [Google Scholar]
  • 40.Kahne D, Walker S, Cheng Y, Vanengen D. J Am Chem Soc. 1989;111:6881–6882. [Google Scholar]
  • 41.Yamamoto T, Hayakawa T, Yoshino M, Hata SI, Hirayama Y. Org Prep Proced Int. 2000;32:192–196. [Google Scholar]
  • 42.Varma RS, Saini RK, Meshram HM. Tet Lett. 1997;38:6525–6528. [Google Scholar]
  • 43.Bower JF, Williams JMJ. Tet Lett. 1994;35:7111–7114. [Google Scholar]
  • 44.Mirkhani V, Tangestaninejad S, Moghadam M, Mohammadpoor-Baltork I, Kargar H. J Mol Catal. 2005;242:251–255. doi: 10.1016/j.bmc.2005.02.012. [DOI] [PubMed] [Google Scholar]
  • 45.Kantam ML, Neelima B, Reddy CV, Chaudhuri MK, Dehury SK. Catal Lett. 2004;95:19–22. [Google Scholar]
  • 46.Peng Y, Feng X, Cui X, Jiang Y, Chan ASC. Synthetic Commun. 2001;31:2287–2296. [Google Scholar]
  • 47.Bonadies F, De Angelis F, Locati L, Scettri A. Tet Lett. 1996;37:7129–7130. [Google Scholar]
  • 48.Webb KS. Tet Lett. 1994;35:3457–3460. [Google Scholar]
  • 49.Hajipour AR. Iran J Sci Technol. 1998;22:205–207. [Google Scholar]
  • 50.Hirano M, Tomaru J, Morimoto T. B Chem Soc Jpn. 1991;64:3752–3754. [Google Scholar]
  • 51.Chen M-Y, Patkar Laxmikant N, Chen H-T, Lin C-C. Carbohyd Res. 2003;338:1327–1332. doi: 10.1016/s0008-6215(03)00164-2. [DOI] [PubMed] [Google Scholar]
  • 52.Park WKC, Auer M, Jaksche H, Wong CH. J Am Chem Soc. 1996;118:10150–10155. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES